Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. Ginsburg KS, Liang MH, Newcomer L, et al.: Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 1992, 117:997–1002.
2. Finazzi G, Brancaccio V, Moia M, et al.: Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four year prospective study from the Italian registry. Am J Med 1996, 100:530–536.
3. Vaarala O, Mänttäri M, Manninen V, et al.: Anticardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation 1995, 91:23–27.
4. Silver RM, Draper ML, Scott JR, et al.: Clinical consequences of antiphospholipid antibodies: an historic cohort study. Obst Gynecol 1994, 83:372–377.
5. Shah N, Khamashta MA, Atsumi T, Hughes GRV: Outcome of patients with anticardiolipin antibodies: a 10 years follow-up of 52 patients. Lupus 1998, 7:3–6.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献